missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18112414

eIF2B3 Antibody (OTI1A4), Alexa Fluor™ 750, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-71397AF750

Product Code. 18112414

  • £595.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

eIF2B3 Monoclonal specifically detects eIF2B3 in Human, Mouse, Rat, Canine samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

eIF2B3
Monoclonal
Alexa Fluor 750
50 mM sodium borate with 0.05% sodium azide
EIF2B3
Full length recombinant protein of human eIF2B3 (NP_065098) produced in HEK293T cells.
Primary
Human, Mouse, Rat, Canine
IgG1
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI1A4
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
EIF-2B, eIF-2B GDP-GTP exchange factor subunit gamma, EIF2Bgamma, eukaryotic translation initiation factor 2B, subunit 3 (gamma, 58kD), eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa, translation initiation factor eIF-2B subunit gamma
Mouse
0.1 mL
8891
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.